Can Moderna Keep the Beat Streak Alive This Earnings Season?

Moderna (MRNA) is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat estimates by 7.06% in the last reported quarter. The Zacks Consensus Estimate for sales and earnings is pegged at $127 million and a loss of$2.91 per share, respectively. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Factors Shaping MRNA’s Upcoming ResultsThe company is likely to have generated a major portion of its revenues from selling its COVID-19 va ...